The first-line regimens of Helicobacter pylori eradication in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Chan Hyuk | - |
dc.date.accessioned | 2021-07-30T05:12:14Z | - |
dc.date.available | 2021-07-30T05:12:14Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2017-05 | - |
dc.identifier.issn | 1738429X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3539 | - |
dc.description.abstract | Approximately half of the world's population is infected by Helicobacter pylori, which causes various gastrointestinal diseases including gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue lymphoma, and gastric cancer. The conventional triple therapy, that consists of proton pump inhibitor (PPI), amoxicillin, and clarithromycin, is widely used in Korea because of high resistance rates of H. pylori against metronidazole. Recently, however, clarithromycin-resistance rates have also increased and the eradication rate of conventional triple therapy has been unacceptable. In order to increase the eradication rate of H. pylori, various regimens have been suggested. Understanding H. pylori eradication regimens will help select drugs in the management of H. pylori infection. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 한양대학교 의과대학 | - |
dc.title | The first-line regimens of Helicobacter pylori eradication in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Chan Hyuk | - |
dc.identifier.doi | 10.7599/hmr.2017.37.1.2 | - |
dc.identifier.bibliographicCitation | Hanyang Medical Reviews, v.37, no.1, pp.2 - 9 | - |
dc.relation.isPartOf | Hanyang Medical Reviews | - |
dc.citation.title | Hanyang Medical Reviews | - |
dc.citation.volume | 37 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 2 | - |
dc.citation.endPage | 9 | - |
dc.type.rims | ART | - |
dc.description.journalClass | 3 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Helicobacter pylori | - |
dc.subject.keywordAuthor | Proton pump inhibitor | - |
dc.subject.keywordAuthor | Antibiotics | - |
dc.subject.keywordAuthor | Eradication | - |
dc.identifier.url | https://synapse.koreamed.org/articles/1044306 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.